COVID-19: Implications for Managing Antiretroviral Therapy in Patients With HIV

In this collection of commentaries expert faculty review the guidance and provide expert perspective on how to manage ART in patients with HIV during the COVID-19 pandemic topics include maintaining stable ART COVID-19 risk in persons with HIV and switching ART.

Share

Program Content

Activities

COVID-19 Risk and ART
COVID-19 Risk in Patients With HIV: Implications for ART Management
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: April 10, 2020

Expires: April 09, 2021

COVID-19 and ART Access
Ensuring Uninterrupted ART for Patients With HIV During the COVID-19 Pandemic
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: April 21, 2020

Expires: April 20, 2021

Retaining PWH in Care During COVID-19
Retaining Unsuppressed Patients in HIV Care During the COVID-19 Pandemic
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: August 14, 2020

Expires: August 13, 2021

COVID-19 Risk in PWH
COVID-19 Risk in PWH: Addressing Common Patient Concerns
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: October 12, 2020

Expires: October 11, 2021

Faculty

cover img faculity

Princy N. Kumar, MD

Professor of Medicine and Microbiology
Division of Infectious Diseases
Georgetown University Hospital
Division Chief
Division of Infectious Diseases and Travel Medicine
Department of Internal Medicine
Medstar Georgetown University Hospital
Washington, DC

cover img faculity

Renslow Sherer, MD

Professor of Medicine
Section of Infectious Diseases and Global Health
University of Chicago
Chicago, Illinois

cover img faculity

David A. Wohl, MD

Professor of Medicine
School of Medicine
Site Leader, Global Clinical Trials Unit-Chapel Hill
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina

Provided by

ProCE Banner

Supporters

Educational grant provided by:

Theratechnologies